Enanta Pharmaceuticals (ENTA) Current Leases (2016 - 2026)
Enanta Pharmaceuticals' (ENTA) quarterly Current Leases came in at $3.8 million in Q1 2026, up 71.17% YoY from $2.2 million in Q1 2025, and up 14.36% on a QoQ basis from $3.3 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) Current Leases (2016 - 2026) Analysis & Trends
Enanta Pharmaceuticals (ENTA) has 10 years of Current Leases data on file, last reported at $3.8 million in Q1 2026.
- Quarterly Current Leases rose 71.17% year-over-year to $3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 71.17% YoY) and the FY2025 annual result came in at $3.1 million, up 106.43% from the prior year.
- Current Leases climbed to $3.8 million in Q1 2026, from $3.3 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $5.4 million in Q2 2023 to a low of $1.0 million in Q4 2024.
- A 5-year average of $3.3 million and a median of $3.1 million in 2025 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2024 — Current Leases slumped 79.74% — and 2025, when it jumped 226.74%.
- Tracing ENTA's Current Leases over 5 years: stood at $3.5 million in 2022, then surged by 42.46% to $5.0 million in 2023, then tumbled by 79.74% to $1.0 million in 2024, then jumped by 226.74% to $3.3 million in 2025, then increased by 14.36% to $3.8 million in 2026.
- The last three Current Leases figures came in at $3.8 million (Q1 2026), $3.3 million (Q4 2025), and $3.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Enanta Pharmaceuticals | 383.29 Mn | 193.78 Mn | - | 3.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.91 Mn |
| Mar 31, 2026 | 3.76 Mn |
| Dec 31, 2025 | 3.29 Mn |
| Sep 30, 2025 | 3.15 Mn |
| Jun 30, 2025 | 2.39 Mn |
| Mar 31, 2025 | 2.20 Mn |
| Dec 31, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Mar 31, 2024 | 3.58 Mn |
| Dec 31, 2023 | 4.97 Mn |
| Sep 30, 2023 | 5.28 Mn |
| Jun 30, 2023 | 5.37 Mn |
| Mar 31, 2023 | 4.92 Mn |
| Dec 31, 2022 | 3.49 Mn |
| Sep 30, 2022 | 2.89 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 3.01 Mn |
| Dec 31, 2021 | 3.47 Mn |
| Sep 30, 2021 | 4.20 Mn |